Associated Papers
PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes.
Vales-Villamarín C et al.
Frontiers in Pharmacology, 2021
Pro12Ala polymorphism in PPAR-gamma2 and dementia in Chinese nonagenarians/centenarians.
Yue JR et al.
Age (dordrecht, Netherlands), 2010
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S et al.
Diabetes, 2009
Association of glucose transporter 1 polymorphisms with type 2 diabetes in the Tunisian population.
Makni K et al.
Diabetes/metabolism Research and Reviews, 2008
Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC et al.
American Journal of Nephrology, 2008
Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.
Kuriki K et al.
Cancer Science, 2006
Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population.
Meirhaeghe A et al.
Molecular Genetics and Metabolism, 2005
Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects.
Kim KS et al.
Metabolism: Clinical and Experimental, 2004
Select a paper to view details